I just saw this article that talks about using Prednisone and MMF to treat EPS:
http://web.me.com/rogerrodby/RUMC_Renal_Resident_Orientation/Reading_List_files/SEP%20AJKD%2008.pdfEncapsulating peritoneal sclerosis is a rare, but potentially lethal, complication of peritoneal dialysis.
Treatment of patients with encapsulating peritoneal sclerosis is controversial. Conservative treatment carries
a poor outcome, and immunosuppressive drugs are now used frequently. Most commonly, these immunosuppressive
regimens include steroids with or without azathioprine or cyclosporine. Mycophenolate mofetil is
a reversible DNA synthesis inhibitor that frequently replaces azathioprine in renal transplantation because of
its improved immunosuppressive potency and better side-effect profile. We report 3 cases of encapsulating
peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients for which an association of
prednisone and mycophenolate mofetil significantly modified the evolution of the disease. All 3 patients
showed significant improvement within a month and are still alive more than 2 years after the diagnosis of
encapsulating peritoneal sclerosis. None experienced a relapse or abdominal symptoms, and body weights
are stable. This is the first report of 3 cases of successful treatment of patients with encapsulating peritoneal
sclerosis with prednisone and mycophenolate mofetil.